225Ac-SS0110

· Ariceum Therapeutics GmbH

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 225Ac-SS0110, covering 2026-02-05 to 2026-02-05. Get the full timeline:

Most recent: Clinical Trial Update: Study of 225Ac-SS0110 in Subjects With ES-SCLC or MCC (SANTANA-225 ) [Phase 1, Phase 2]